End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
47,750 KRW | +0.42% | +2.91% | +31.54% |
2023 | Cosmecca Korea Co., Ltd.(KOSDAQ:A241710) added to S&P Global BMI Index | CI |
2023 | Cosmecca Korea Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 48% by 2026.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+31.54% | 375M | - | ||
-2.29% | 259B | B- | ||
+18.81% | 20.66B | B+ | ||
0.00% | 19.04B | - | - | |
+17.33% | 12.68B | A- | ||
-13.77% | 9.25B | A- | ||
+23.03% | 8.07B | B+ | ||
+11.07% | 6.01B | B | ||
-12.20% | 3.98B | B+ | ||
-16.08% | 3.87B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A241710 Stock
- Ratings Cosmecca Korea Co., Ltd.